ST101 clinical trials

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

This study is testing a new drug, ST101, for people with advanced cancers like breast cancer, melanoma, and glioblastoma. It aims to see if the drug is safe, how much to give, and if it could help shrink tumors. It's for adults whose cancer hasn't responded to other treatments.